Niagen Bioscience Inc (NAGE)

$3.47 -0.04 (-1.14%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	268.40M
Revenue (ttm)	129.42M
Net Income (ttm)	17.38M
EPS (ttm)	N/A
PE Ratio	18.16
Forward PE	15.92
Profit Margin	13.43%
Debt to Equity Ratio	0.00

Volume	549,102
Avg Vol	869,996
Day's Range	N/A - N/A
Shares Out	79.64M
Stochastic %K	26%
Beta	2.08
Analysts	Strong Sell
Price Target	$11.25

Company Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, in...

Industry: Biotechnology

Sector: Healthcare

Phone: 310 388 6706

Website: www.niagenbioscience.com

Address:

10900 Wilshire Blvd, Suite 600, Los Angeles, United States